Brii Biosciences Provides Corporate Updates and Reports 2026 InterimBy FinMar NewsAugust 20, 2026Topline Data from Phase 2b Studies Inform HBV Functional Cure Strategy; Additional Data Expected in 2H 2026 Emerging Discovery Programs Build Momentum BRII-5395 mRNA Cancer Vaccine…
